Phenotypic and functional characteristics of HIV-specific CD8 T cells and gag sequence variability after autologous dendritic cells based therapeutic vaccine (Q61767214)

From Wikidata

Jump to navigation Jump to search

article

Language	Label	Description	Also known as
English	Phenotypic and functional characteristics of HIV-specific CD8 T cells and gag sequence variability after autologous dendritic cells based therapeutic vaccine	article

Statements

scholarly article

1 reference

Europe PubMed Central

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:19712765%20AND%20SRC:MED&resulttype=core&format=json

6 February 2020

Phenotypic and functional characteristics of HIV-specific CD8 T cells and gag sequence variability after autologous dendritic cells based therapeutic vaccine (English)

1 reference

Europe PubMed Central

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:19712765%20AND%20SRC:MED&resulttype=core&format=json

6 February 2020

molecular medicine

0 references

therapeutic vaccine

1 reference

based on heuristic

inferred from title

1 reference

based on heuristic

inferred from title

9

1 reference

Europe PubMed Central

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:19712765%20AND%20SRC:MED&resulttype=core&format=json

6 February 2020

author name string

Anna López

1

1 reference

Europe PubMed Central

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:19712765%20AND%20SRC:MED&resulttype=core&format=json

6 February 2020

Nils van der Lubbe

2

1 reference

Europe PubMed Central

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:19712765%20AND%20SRC:MED&resulttype=core&format=json

6 February 2020

Sonsoles Sánchez-Palomino

3

1 reference

Europe PubMed Central

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:19712765%20AND%20SRC:MED&resulttype=core&format=json

6 February 2020

Mireia Arnedo

4

1 reference

Europe PubMed Central

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:19712765%20AND%20SRC:MED&resulttype=core&format=json

6 February 2020

Meritxell Nomdedeu

5

1 reference

Europe PubMed Central

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:19712765%20AND%20SRC:MED&resulttype=core&format=json

6 February 2020

Pedro Castro

6

1 reference

Europe PubMed Central

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:19712765%20AND%20SRC:MED&resulttype=core&format=json

6 February 2020

Meritxell Guilà

7

1 reference

Europe PubMed Central

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:19712765%20AND%20SRC:MED&resulttype=core&format=json

6 February 2020

Teresa Gallart

10

1 reference

Europe PubMed Central

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:19712765%20AND%20SRC:MED&resulttype=core&format=json

6 February 2020

Montserrat Plana

12

1 reference

Europe PubMed Central

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:19712765%20AND%20SRC:MED&resulttype=core&format=json

6 February 2020

Maria J Maleno

8

1 reference

Europe PubMed Central

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:19712765%20AND%20SRC:MED&resulttype=core&format=json

6 February 2020

José M Gatell

11

1 reference

Europe PubMed Central

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:19712765%20AND%20SRC:MED&resulttype=core&format=json

6 February 2020

language of work or name

0 references

publication date

26 August 2009

1 reference

Europe PubMed Central

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:19712765%20AND%20SRC:MED&resulttype=core&format=json

6 February 2020

1 reference

Europe PubMed Central

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:19712765%20AND%20SRC:MED&resulttype=core&format=json

6 February 2020

27

1 reference

Europe PubMed Central

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:19712765%20AND%20SRC:MED&resulttype=core&format=json

6 February 2020

44

1 reference

Europe PubMed Central

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:19712765%20AND%20SRC:MED&resulttype=core&format=json

6 February 2020

6166-6178

1 reference

Europe PubMed Central

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:19712765%20AND%20SRC:MED&resulttype=core&format=json

6 February 2020

CD8 T cell dysfunction during chronic viral infection.

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2009.08.021

7 January 2021

Dynamics of T cell responses in HIV infection

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2009.08.021

7 January 2021

Phenotypic analysis of antigen-specific T lymphocytes

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2009.08.021

7 January 2021

Mechanisms of HIV-1 escape from immune responses and antiretroviral drugs

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2009.08.021

7 January 2021

The role of CD4(+) T helper cells in the cytotoxic T lymphocyte response to HIV-1.

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2009.08.021

7 January 2021

Factors related to loss of HIV-specific cytotoxic T lymphocyte activity.

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2009.08.021

7 January 2021

Presence of distinct subsets of cytolytic CD8+ T cells in chronic HIV infection.

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2009.08.021

7 January 2021

Memory CD8 T-cell differentiation during viral infection

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2009.08.021

7 January 2021

Fully differentiated HIV-1 specific CD8+ T effector cells are more frequently detectable in controlled than in progressive HIV-1 infection

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2009.08.021

7 January 2021

Estimating Costs and Benefits of CTL Escape Mutations in SIV/HIV Infection

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2009.08.021

7 January 2021

Conflicting selective forces affect T cell receptor contacts in an immunodominant human immunodeficiency virus epitope

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2009.08.021

7 January 2021

Cytotoxic T lymphocyte responses to human immunodeficiency virus: control and escape.

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2009.08.021

7 January 2021

Altering effects of antigenic variations in HIV-1 on antiviral effectiveness of HIV-specific CTLs.

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2009.08.021

7 January 2021

Characterization of virus-specific CD8(+) effector T cells in the course of HIV-1 infection: longitudinal analyses in slow and rapid progressors

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2009.08.021

7 January 2021

Selection, transmission, and reversion of an antigen-processing cytotoxic T-lymphocyte escape mutation in human immunodeficiency virus type 1 infection

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2009.08.021

7 January 2021

HIV and SIV CTL escape: implications for vaccine design

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2009.08.021

7 January 2021

Loss of HIV-1-specific CD8+ T cell proliferation after acute HIV-1 infection and restoration by vaccine-induced HIV-1-specific CD4+ T cells

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2009.08.021

7 January 2021

Determinants of human immunodeficiency virus type 1 escape from the primary CD8+ cytotoxic T lymphocyte response

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2009.08.021

7 January 2021

Therapeutic dendritic-cell vaccine for simian AIDS.

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2009.08.021

7 January 2021

Programming CD8+ T cells for effective immunotherapy.

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2009.08.021

7 January 2021

Accelerated CD8+ T-cell memory and prime-boost response after dendritic-cell vaccination.

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2009.08.021

7 January 2021

Dendritic cells and the control of immunity

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2009.08.021

7 January 2021

Dendritic cell subsets in health and disease.

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2009.08.021

7 January 2021

Therapeutic Immunization with Dendritic Cells Loaded with Heat‐Inactivated Autologous HIV‐1 in Patients with Chronic HIV‐1 Infection

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2009.08.021

7 January 2021

Comparison of twice-daily stavudine plus once- or twice-daily didanosine and nevirapine in early stages of HIV infection: the Scan Study

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2009.08.021

7 January 2021

Effector and memory CTL differentiation

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2009.08.021

7 January 2021

HIV-specific CD8(+) T cells produce antiviral cytokines but are impaired in cytolytic function

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2009.08.021

7 January 2021

Granule-dependent mechanisms of lysis are defective in CD8 T cells of HIV-infected, antiretroviral therapy-treated individuals.

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2009.08.021

7 January 2021

Memory CD8+ T cells vary in differentiation phenotype in different persistent virus infections

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2009.08.021

7 January 2021

Human CD8(+) T-cell differentiation in response to viruses

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2009.08.021

7 January 2021

Human immunodeficiency virus type 1 (HIV-1)-specific CD8+ T(EMRA) cells in early infection are linked to control of HIV-1 viremia and predict the subsequent viral load set point

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2009.08.021

7 January 2021

Vaccine-induced CD8+ central memory T cells in protection from simian AIDS.

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2009.08.021

7 January 2021

Epitope cross-reactivity frequently differs between central and effector memory HIV-specific CD8+ T cells.

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2009.08.021

7 January 2021

Assessment of migration of HIV-1-loaded dendritic cells labeled with 111In-oxine used as a therapeutic vaccine in HIV-1-infected patients

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2009.08.021

7 January 2021

CD25(+)CD4(+) regulatory T cells from the peripheral blood of asymptomatic HIV-infected individuals regulate CD4(+) and CD8(+) HIV-specific T cell immune responses in vitro and are associated with favorable clinical markers of disease status

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2009.08.021

7 January 2021

Immunization of patients with metastatic melanoma using both class I- and class II-restricted peptides from melanoma-associated antigens

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2009.08.021

7 January 2021

Antigen-bearing immature dendritic cells induce peptide-specific CD8(+) regulatory T cells in vivo in humans

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2009.08.021

7 January 2021

Resting dendritic cells induce peripheral CD8+ T cell tolerance through PD-1 and CTLA-4.

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2009.08.021

7 January 2021

The PD-1-PD-L pathway in immunological tolerance

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2009.08.021

7 January 2021

PD-1 is a regulator of virus-specific CD8+ T cell survival in HIV infection

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2009.08.021

7 January 2021

Role of PD-1 and its ligand, B7-H1, in early fate decisions of CD8 T cells

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2009.08.021

7 January 2021

PD-1 expression on human CD8 T cells depends on both state of differentiation and activation status.

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2009.08.021

7 January 2021

Epitope Escape Mutation and Decay of Human Immunodeficiency Virus Type 1-Specific CTL Responses

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2009.08.021

7 January 2021

Impact of Gag sequence variability on level, phenotype, and function of anti-HIV Gag-specific CD8(+) cytotoxic T lymphocytes in untreated chronically HIV-infected patients.

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2009.08.021

7 January 2021

Lack of viral escape and defective in vivo activation of human immunodeficiency virus type 1-specific cytotoxic T lymphocytes in rapidly progressive infection

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2009.08.021

7 January 2021

based on heuristic

inferred from DOI database lookup

Identifiers

10.1016/J.VACCINE.2009.08.021

1 reference

Europe PubMed Central

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:19712765%20AND%20SRC:MED&resulttype=core&format=json

6 February 2020

1 reference

Europe PubMed Central

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:19712765%20AND%20SRC:MED&resulttype=core&format=json

6 February 2020

Sitelinks

Wikipedia(0 entries)

Wikibooks(0 entries)

Wikinews(0 entries)

Wikiquote(0 entries)

Wikisource(0 entries)

Wikiversity(0 entries)

Wikivoyage(0 entries)

Wiktionary(0 entries)

Multilingual sites(0 entries)

Retrieved from "https://www.wikidata.org/w/index.php?title=Q61767214&oldid=1953598169"